You are here: Home: CCU 3 | 2003: Faculty Disclosures


FACULTY DISCLOSURES

As a provider accredited by the ACCME, it is the policy of NL Communications Inc to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:

Norman Wolmark, MD
No financial interests or affiliations to disclose
John Zalcberg, MB, BS, PhD, FRACP
Honorarium: Sanofi-Synthelabo Inc, Roche Laboratories Inc, Novartis
Pharmaceuticals Corporation, Pharmacia Corporation, Aventis
Pharmaceuticals Inc
Board Member: Progen Industries
Yehuda Patt, MD
Grants/Research Support: Roche Laboratories Inc, Sanofi-Synthelabo Inc,
Pharmacia Corporation
Honorarium: Roche Laboratories Inc, Sanofi-Synthelabo Inc
Lawrence D Wagman, MD, FACS
No financial interests or affiliations to disclose

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. NL Communications Inc does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.

 

Table of Contents Top of Page

Home

Editor’s Note
 
Norman Wolmark, MD
- Select publications
 
John Zalcberg, MB, BS, PhD, FRACP
- Select publications
 
Yehuda Patt, MD
- Select publications
 
Lawrence D Wagman, MD, FACS
- Select publications

Faculty Disclosures

A CME Audio Series and Activity

Editor's office

 

Terms of use and general disclaimer
© NL Communications, Inc. 2003. All rights reserved.